| 2017-05-16 | Gallagher Carol Giltner | - | Sale+OE | 1,184 | $15.25 | $18,056.00 | -1.1% | → |
| 2017-05-16 | Clark Mitchall G. | EVP & Chief R & QA Officer | Sale+OE | 3,873 | $15.25 | $59,063.25 | -2.5% | → |
| 2017-05-16 | Soffer Gad | EVP & Chief Strategy Officer | Sale+OE | 12,674 | $15.16 | $192,098.06 | -2.4% | → |
| 2017-05-15 | MCGRATH JOHN | EVP & Chief Financial Officer | Sale+OE | 2,000 | $14.95 | $29,900.00 | -1.6% | → |
| 2017-05-15 | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sale+OE | 7,604 | $14.99 | $113,983.96 | -2.0% | → |
| 2017-04-26 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,200 | $17.56 | $126,405.00 | -0.5% | → |
| 2017-04-17 | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sell | 6,000 | $17.28 | $103,680.00 | -1.6% | → |
| 2017-04-11 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,200 | $17.03 | $122,598.00 | -0.7% | → |
| 2017-03-28 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 16,000 | $20.06 | $320,943.66 | -1.1% | → |
| 2017-03-23 | MCGRATH JOHN | EVP & Chief Financial Officer | Sell | 14,000 | $20.65 | $289,045.00 | -5.7% | → |
| 2017-03-17 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 30,800 | $19.38 | $596,808.00 | -2.0% | → |
| 2017-03-15 | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sell | 6,000 | $19.60 | $117,600.00 | -1.5% | → |
| 2017-03-10 | Soffer Gad | EVP & Chief Strategy Officer | Sell | 2,500 | $20.00 | $50,000.00 | -0.9% | → |
| 2017-03-10 | MCGRATH JOHN | EVP & Chief Financial Officer | Sell | 24,000 | $20.00 | $480,000.00 | -15.9% | → |
| 2017-02-21 | MCGRATH JOHN | EVP & Chief Financial Officer | Sell | 9,000 | $15.14 | $136,260.00 | -5.6% | → |
| 2017-02-16 | Ciechanover Isaac E. | Chief Executive Officer | Sale+OE | 4,800 | $15.56 | $74,664.00 | -0.7% | → |
| 2017-02-16 | Gallagher Carol Giltner | - | Sale+OE | 1,183 | $16.10 | $19,046.30 | -1.1% | → |
| 2017-02-16 | Clark Mitchall G. | EVP & Chief R & QA Officer | Sale+OE | 3,059 | $15.96 | $48,821.64 | -2.0% | → |
| 2017-02-16 | Soffer Gad | EVP & Chief Strategy Officer | Sale+OE | 14,273 | $15.42 | $220,144.26 | -2.6% | → |
| 2017-02-15 | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sale+OE | 7,604 | $15.49 | $117,785.96 | -1.9% | → |
| 2017-02-10 | Soffer Gad | EVP & Chief Strategy Officer | Sell | 6,274 | $15.47 | $97,029.08 | -1.1% | → |
| 2017-02-09 | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sell | 13,975 | $15.46 | $216,053.50 | -3.4% | → |
| 2017-02-09 | Turner Heather D | EVP, General Counsel & Sec. | Sell | 12,215 | $15.72 | $192,066.68 | -6.6% | → |
| 2017-02-03 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,800 | $13.66 | $65,568.00 | -0.7% | → |
| 2017-01-18 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 6,000 | $14.24 | $85,416.00 | -0.8% | → |
| 2017-01-17 | Haqq Christopher | EVP, R&D & Chief Scientific Of | Sell | 6,000 | $14.27 | $85,620.00 | -1.6% | → |
| 2017-01-06 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 8,400 | $16.89 | $141,864.00 | -1.1% | → |
| 2016-12-23 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,800 | $15.22 | $73,073.00 | -0.4% | → |
| 2016-12-15 | Haqq Christopher | Chief Medical Officer | Sell | 6,000 | $15.40 | $92,400.00 | -1.6% | → |
| 2016-12-07 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,200 | $17.93 | $129,060.00 | -0.9% | → |
| 2016-11-23 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 2,500 | $18.40 | $46,000.00 | -0.6% | → |